Suheung Co., Ltd. (KRX:008490)
18,330
-640 (-3.37%)
Apr 2, 2026, 3:30 PM KST
Suheung Revenue
In the year 2025, Suheung had annual revenue of 722.31B KRW with 10.57% growth. Suheung had revenue of 166.40B in the quarter ending December 31, 2025, with 12.00% growth.
Revenue
722.31B
Revenue Growth
+10.57%
P/S Ratio
0.29
Revenue / Employee
978.74M
Employees
738
Market Cap
211.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 722.31B | 69.04B | 10.57% |
| Dec 31, 2024 | 653.26B | 58.70B | 9.87% |
| Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
| Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
| Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewon Pharmaceutical | 590.70B |
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| Samjin Pharmaceuticals | 274.03B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| Kyongbo Pharmaceutical | 264.10B |
| JW Lifescience | 257.83B |
| Whan In Pharm | 255.21B |
| Samil Pharmaceutical Co.,Ltd | 215.04B |